Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - Deferred ChargesDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsShares Outstanding
Ratios

MDxHealth (MDXH) EBIAT: 2021-2025

Historic EBIAT for MDxHealth (MDXH) over the last 5 years, with Sep 2025 value amounting to -$8.0 million.

  • MDxHealth's EBIAT rose 28.41% to -$8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $668,000, marking a year-over-year increase of 103.26%. This contributed to the annual value of -$38.1 million for FY2024, which is 11.60% up from last year.
  • MDxHealth's EBIAT amounted to -$8.0 million in Q3 2025, which was down 8.65% from -$7.4 million recorded in Q2 2025.
  • In the past 5 years, MDxHealth's EBIAT ranged from a high of $18.1 billion in Q2 2022 and a low of -$13.3 billion during Q2 2021.
  • Its 3-year average for EBIAT is -$4.7 million, with a median of -$8.5 million in 2024.
  • Its EBIAT has fluctuated over the past 5 years, first surged by 236.13% in 2022, then plummeted by 100.06% in 2023.
  • MDxHealth's EBIAT (MRQ) stood at -$20.9 million in 2021, then soared by 159.46% to $12.4 million in 2022, then fell by 13.81% to $10.7 million in 2023, then tumbled by 36.18% to $6.8 million in 2024, then tumbled by 217.09% to -$8.0 million in 2025.
  • Its last three reported values are -$8.0 million in Q3 2025, -$7.4 million for Q2 2025, and $9.2 million during Q1 2025.